{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:19:08Z","timestamp":1790630348562,"version":"4.1.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,9,1]]},"abstract":"<jats:p>A murine model of minor histocompatibility antigen-mismatched bone marrow transplantation (BMT) was used to study the role of timing of donor lymphocyte infusion (DLI) in eliciting graft-versus-host (GVH) and graft-versus-leukemia (GVL) reactivity. We gave DLI at weeks 3 and 12 after BMT and related its ability to induce a GVL effect with (1) evolution of T cell chimeric status and (2) the extent to which DLI could elicit lymphohematopoietic GVH (LHGVH) reactivity. All mice remained free of GVH disease, but only week 3 DLI chimeras exhibited a significant GVL response when challenged with host-type leukemia cells. In these week 3 DLI chimeras, host-reactive T cells were found to proliferate in vivo (5- [and-6]-carboxyfluorescein diacetate, succinimidyl esther [CFSE]-labeled DLI inocula, TCR-V\u03b26+ T-cell frequency) and T-cell chimerism rapidly converted from mixed into complete donor type, indicating the occurrence of LHGVH reactivity. In week 12 chimeras, DLI elicited none of the activities noted at week 3. Yet, in both instances, splenocytes, recovered following DLI, generated an equally strong antihost proliferative response in a mixed lymphocyte reaction, thereby arguing against a decisive role of regulatory cells. The lack of in vivo LHGVH reactivity after week 12 DLI was associated with a substantially increased level of pre-existing host-type T-cell chimerism. We conclude that elicitation of a GVL effect may require LHGVH reactivity and that the reason why timing of DLI was critical for obtaining LHGVH reactivity and the desired GVL effect may lie in the evolution of chimeric status. A possible direct involvement of residual host-type antigen-presenting cells in eliciting LHGVH reactivity after DLI should be studied using models that allow chimerism analysis in non\u2013T-cell lineages.<\/jats:p>","DOI":"10.1182\/blood-2002-02-0419","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:48:18Z","timestamp":1033508898000},"page":"1894-1902","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants"],"prefix":"10.1182","volume":"100","author":[{"given":"An D.","family":"Billiau","sequence":"first","affiliation":[{"name":"From the Laboratory of Experimental Transplantation and Laboratory of Experimental Radiobiology, University of Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Fevery","sequence":"additional","affiliation":[{"name":"From the Laboratory of Experimental Transplantation and Laboratory of Experimental Radiobiology, University of Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Rutgeerts","sequence":"additional","affiliation":[{"name":"From the Laboratory of Experimental Transplantation and Laboratory of Experimental Radiobiology, University of Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Landuyt","sequence":"additional","affiliation":[{"name":"From the Laboratory of Experimental Transplantation and Laboratory of Experimental Radiobiology, University of Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Waer","sequence":"additional","affiliation":[{"name":"From the Laboratory of Experimental Transplantation and Laboratory of Experimental Radiobiology, University of Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111821461312900_B1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.med.50.1.369","article-title":"The graft-versus-leukemia effects of allogeneic cell therapy.","volume":"50","author":"Porter","year":"1999","journal-title":"Annu Rev Med."},{"key":"2019111821461312900_B2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","article-title":"Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.","volume":"87","author":"Slavin","year":"1996","journal-title":"Blood."},{"key":"2019111821461312900_B3","first-page":"1553","article-title":"Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.","volume":"23","author":"Slavin","year":"1995","journal-title":"Exp Hematol."},{"key":"2019111821461312900_B4","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood."},{"key":"2019111821461312900_B5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199401133300204","article-title":"Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.","volume":"330","author":"Porter","year":"1994","journal-title":"N Engl J Med."},{"key":"2019111821461312900_B6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2141.2000.02196.x","article-title":"Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.","volume":"111","author":"Champlin","year":"2000","journal-title":"Br J Haematol."},{"key":"2019111821461312900_B7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00062752-200111000-00006","article-title":"Cellular therapy: donor lymphocyte infusion.","volume":"8","author":"Peggs","year":"2001","journal-title":"Curr Opin Hematol."},{"key":"2019111821461312900_B8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001622-200103000-00003","article-title":"Nonmyeloablative hematopoietic cell transplantation.","volume":"13","author":"Feinstein","year":"2001","journal-title":"Curr Opin Oncol."},{"key":"2019111821461312900_B9","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol."},{"key":"2019111821461312900_B10","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood."},{"key":"2019111821461312900_B11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1083-8791(00)70056-5","article-title":"Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.","volume":"6","author":"Spitzer","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019111821461312900_B12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood."},{"key":"2019111821461312900_B13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","article-title":"Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.","volume":"25","author":"Nagler","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"2019111821461312900_B14","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234.421k16_3234_3241","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.","volume":"94","author":"Childs","year":"1999","journal-title":"Blood."},{"key":"2019111821461312900_B15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood."},{"key":"2019111821461312900_B16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood.V94.2.434","article-title":"T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.","volume":"94","author":"Drobyski","year":"1999","journal-title":"Blood."},{"key":"2019111821461312900_B17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/bbmt.1999.v5.pm10392959","article-title":"Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.","volume":"5","author":"Pelot","year":"1999","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019111821461312900_B18","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1084\/jem.168.6.2391","article-title":"Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells.","volume":"168","author":"Sykes","year":"1988","journal-title":"J Exp Med."},{"key":"2019111821461312900_B19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.116.5.1212","article-title":"Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.","volume":"116","author":"Weiden","year":"1976","journal-title":"J Immunol."},{"key":"2019111821461312900_B20","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V95.10.3262","article-title":"Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.","volume":"95","author":"Georges","year":"2000","journal-title":"Blood."},{"key":"2019111821461312900_B21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00007890-200007270-00020","article-title":"Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells.","volume":"70","author":"Sefrioui","year":"2000","journal-title":"Transplantation."},{"key":"2019111821461312900_B22","first-page":"329","article-title":"Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.","volume":"11","author":"Johnson","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"2019111821461312900_B23","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.165.9.4901","article-title":"Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.","volume":"165","author":"Blazar","year":"2000","journal-title":"J Immunol."},{"key":"2019111821461312900_B24","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood.V80.12.2964.2964","article-title":"Cytokine dysregulation and acute graft-versus-host disease.","volume":"80","author":"Antin","year":"1992","journal-title":"Blood."},{"key":"2019111821461312900_B25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00007890-198109000-00005","article-title":"Suppressor cells in transplantation tolerance, I: suppressor cells in the mechanism of tolerance in radiation chimeras.","volume":"32","author":"Tutschka","year":"1981","journal-title":"Transplantation."},{"key":"2019111821461312900_B26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/292355a0","article-title":"Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation.","volume":"292","author":"Tsoi","year":"1981","journal-title":"Nature."},{"key":"2019111821461312900_B27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.138.3.699","article-title":"Cloned natural suppressor cells prevent lethal graft-vs-host disease.","volume":"138","author":"Strober","year":"1987","journal-title":"J Immunol."},{"key":"2019111821461312900_B28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0008-8749(90)90131-A","article-title":"Natural suppressor cells in spleens of irradiated, bone marrow- reconstituted mice and normal bone marrow: lack of Sca-1 expression and enrichment by depletion of Mac1-positive cells.","volume":"127","author":"Sykes","year":"1990","journal-title":"Cell Immunol."},{"key":"2019111821461312900_B29","first-page":"287","article-title":"Cellular modulation of acute graft-vs.-host disease.","volume":"3","author":"Colby","year":"1997","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019111821461312900_B30","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.4049\/jimmunol.163.12.6479","article-title":"Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.","volume":"163","author":"Johnson","year":"1999","journal-title":"J Immunol."},{"key":"2019111821461312900_B31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation.","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood."},{"key":"2019111821461312900_B32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","article-title":"Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.","volume":"73","author":"Sullivan","year":"1989","journal-title":"Blood."},{"key":"2019111821461312900_B33","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V77.11.2515.2515","article-title":"Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.","volume":"77","author":"Truitt","year":"1991","journal-title":"Blood."},{"key":"2019111821461312900_B34","first-page":"445","article-title":"The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia.","volume":"8","author":"OKunewick","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"2019111821461312900_B35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI118134","article-title":"Recognition of clonogenic leukemic cells, remission bone marrow and HLA- identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.","volume":"96","author":"Faber","year":"1995","journal-title":"J Clin Invest."},{"key":"2019111821461312900_B36","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V75.10.2005.2005","article-title":"Specific recognition of human leukemic cells by allogeneic T cells, II: evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells.","volume":"75","author":"Sosman","year":"1990","journal-title":"Blood."},{"key":"2019111821461312900_B37","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood.V83.4.1060.1060","article-title":"Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones.","volume":"83","author":"van der","year":"1994","journal-title":"Blood."},{"key":"2019111821461312900_B38","first-page":"1167","article-title":"Cellular and cytokine-mediated effects of CD4-positive lymphocyte lines generated in vitro against chronic myelogenous leukemia.","volume":"23","author":"Jiang","year":"1995","journal-title":"Exp Hematol."},{"key":"2019111821461312900_B39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10428199709058328","article-title":"The allogeneic CD4+ T-cell-mediated graft-versus-leukemia effect.","volume":"28","author":"Jiang","year":"1997","journal-title":"Leuk Lymphoma."},{"key":"2019111821461312900_B40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood."},{"key":"2019111821461312900_B41","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood.V75.11.2250.2250","article-title":"Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.","volume":"75","author":"Hauch","year":"1990","journal-title":"Blood."},{"key":"2019111821461312900_B42","first-page":"451","article-title":"Evidence for a possible role of asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia.","volume":"16","author":"O'Kunewick","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"2019111821461312900_B43","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/00007890-199506270-00016","article-title":"Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.","volume":"59","author":"Zeis","year":"1995","journal-title":"Transplantation."},{"key":"2019111821461312900_B44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2141.1996.4941035.x","article-title":"Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells.","volume":"93","author":"Glass","year":"1996","journal-title":"Br J Haematol."},{"key":"2019111821461312900_B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002770050246","article-title":"Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation.","volume":"74","author":"Jiang","year":"1997","journal-title":"Ann Hematol."},{"key":"2019111821461312900_B46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00062752-199811000-00013","article-title":"Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation.","volume":"5","author":"Warren","year":"1998","journal-title":"Curr Opin Hematol."},{"key":"2019111821461312900_B47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.174.1.27","article-title":"Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.","volume":"174","author":"Falkenburg","year":"1991","journal-title":"J Exp Med."},{"key":"2019111821461312900_B48","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V93.7.2336","article-title":"Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.","volume":"93","author":"Mutis","year":"1999","journal-title":"Blood."},{"key":"2019111821461312900_B49","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1073\/pnas.96.15.8639","article-title":"CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells.","volume":"96","author":"Bonnet","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821461312900_B50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1083-8791(00)70014-0","article-title":"Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma.","volume":"6","author":"Orsini","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019111821461312900_B51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","article-title":"Determination of lymphocyte division by flow cytometry.","volume":"171","author":"Lyons","year":"1994","journal-title":"J Immunol Methods."},{"key":"2019111821461312900_B52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb01527.x","article-title":"Exogenous and endogenous mouse mammary tumor virus superantigens.","volume":"131","author":"Acha-Orbea","year":"1993","journal-title":"Immunol Rev."},{"key":"2019111821461312900_B53","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.159.4.1746","article-title":"Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen.","volume":"159","author":"Williams","year":"1997","journal-title":"J Immunol."},{"key":"2019111821461312900_B54","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.4049\/jimmunol.154.10.5542","article-title":"Use of anti-CD3 epsilon F(ab\u2032)2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.","volume":"154","author":"Johnson","year":"1995","journal-title":"J Immunol."},{"key":"2019111821461312900_B55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.171.1.97","article-title":"Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.","volume":"171","author":"Eto","year":"1990","journal-title":"J Exp Med."},{"key":"2019111821461312900_B56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.1830250209","article-title":"Critical role of endogenous Mtv in acute lethal graft-versus-host disease.","volume":"25","author":"Miconnet","year":"1995","journal-title":"Eur J Immunol."},{"key":"2019111821461312900_B57","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.171.4.1381","article-title":"CD8+ T cells respond clonally to Mls-1a-encoded determinants.","volume":"171","author":"MacDonald","year":"1990","journal-title":"J Exp Med."},{"key":"2019111821461312900_B58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.1993.tb01535.x","article-title":"Factors controlling the reactivity of immature and mature T cells to Mls antigens in vivo.","volume":"131","author":"Webb","year":"1993","journal-title":"Immunol Rev."},{"key":"2019111821461312900_B59","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1084\/jem.173.5.1039","article-title":"Reentry of T cells to the adult thymus is restricted to activated T cells.","volume":"173","author":"Agus","year":"1991","journal-title":"J Exp Med."},{"key":"2019111821461312900_B60","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1073\/pnas.87.16.6301","article-title":"Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.","volume":"87","author":"Fukushi","year":"1990","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821461312900_B61","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.152.4.1609","article-title":"Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.","volume":"152","author":"Hollander","year":"1994","journal-title":"J Immunol."},{"key":"2019111821461312900_B62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells.","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science."},{"key":"2019111821461312900_B63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","article-title":"Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings.","volume":"7","author":"Antin","year":"2001","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019111821461312900_B64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2141.2000.01927.x","article-title":"Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse.","volume":"108","author":"Bader","year":"2000","journal-title":"Br J Haematol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/5\/1894\/1254575\/h81702001894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/5\/1894\/1254575\/h81702001894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T19:38:30Z","timestamp":1682365110000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/5\/1894\/106409\/Crucial-role-of-timing-of-donor-lymphocyte"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-02-0419","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9,1]]}}}